158 related articles for article (PubMed ID: 36088606)
1. Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
Schönthal AH; Swenson S; Bonney PA; Wagle N; Simmon VF; Mathew AJ; Hurth KM; Chen TC
J Neurosurg Case Lessons; 2022 Aug; 4(8):. PubMed ID: 36088606
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.
Schönthal AH; Peereboom DM; Wagle N; Lai R; Mathew AJ; Hurth KM; Simmon VF; Howard SP; Taylor LP; Chow F; da Fonseca CO; Chen TC
Neurooncol Adv; 2021; 3(1):vdab005. PubMed ID: 33604574
[TBL] [Abstract][Full Text] [Related]
3. Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models.
Wang W; Swenson S; Cho HY; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2019 Mar; 132(3):959-967. PubMed ID: 30875688
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of motility by NEO100 through the calpain-1/RhoA pathway.
Marín-Ramos NI; Pérez-Hernández M; Tam A; Swenson SD; Cho HY; Thein TZ; Hofman FM; Chen TC
J Neurosurg; 2019 Aug; 133(4):1020-1031. PubMed ID: 31419797
[TBL] [Abstract][Full Text] [Related]
5. Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
Wang W; He H; Zheng L; Zeng S; Cho HY; Kouhi A; Khawli LA; Chen L; Stathopoulos A; Schönthal AH; Epstein AL; Chen TC
J Neurosurg; 2024 Jun; 140(6):1549-1557. PubMed ID: 38157532
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of perillyl alcohol-loaded nanoemulsion and pharmacokinetic study of its metabolite perillic acid in plasma and brain of rats using ultra-performance liquid chromatography/tandem mass spectrometry.
da Silva Santos J; Diedrich C; Machado CS; da Fonseca CO; Khalil NM; Mainardes RM
Biomed Chromatogr; 2021 Apr; 35(4):e5037. PubMed ID: 33238042
[TBL] [Abstract][Full Text] [Related]
7. NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics.
Wang W; Marín-Ramos NI; He H; Zeng S; Cho HY; Swenson SD; Zheng L; Epstein AL; Schönthal AH; Hofman FM; Chen L; Chen TC
Neuro Oncol; 2021 Jan; 23(1):63-75. PubMed ID: 32877532
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of perillyl alcohol and its metabolite perillic acid in plasma and lung after inhalational administration in Wistar rats.
de Lima DC; Rodrigues SV; Boaventura GT; Cho HY; Chen TC; Schönthal AH; Da Fonseca CO
Drug Test Anal; 2020 Feb; 12(2):268-279. PubMed ID: 31800149
[TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats.
Nehra G; Andrews S; Rettig J; Gould MN; Haag JD; Howard SP; Thorne RG
Sci Rep; 2021 Mar; 11(1):6351. PubMed ID: 33737566
[TBL] [Abstract][Full Text] [Related]
11. Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer.
Wang W; He H; Marín-Ramos NI; Zeng S; Swenson SD; Cho HY; Fu J; Beringer PM; Neman J; Chen L; Schönthal AH; Chen TC
Neuro Oncol; 2021 Oct; 23(10):1656-1667. PubMed ID: 33659980
[TBL] [Abstract][Full Text] [Related]
12. The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.
Chen TC; da Fonseca CO; Levin D; Schönthal AH
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959448
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy.
Santos JG; Faria G; Cruz WDCSD; Fontes CA; Schönthal AH; Quirico-Santos T; da Fonseca CO
Surg Neurol Int; 2020; 11():389. PubMed ID: 33282452
[TBL] [Abstract][Full Text] [Related]
14. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.
Santos JG; Da Cruz WMS; Schönthal AH; Salazar MD; Fontes CAP; Quirico-Santos T; Da Fonseca CO
Oncol Lett; 2018 Jan; 15(1):1263-1270. PubMed ID: 29391903
[TBL] [Abstract][Full Text] [Related]
16. Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol.
Garcia DG; de Castro-Faria-Neto HC; da Silva CI; de Souza e Souza KF; Gonçalves-de-Albuquerque CF; Silva AR; de Amorim LM; Freire AS; Santelli RE; Diniz LP; Gomes FC; Faria MV; Burth P
Mol Cancer; 2015 May; 14():105. PubMed ID: 25976744
[TBL] [Abstract][Full Text] [Related]
17. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
19. Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.
Wang W; He H; Zeng S; Cho HY; Minea RO; Swenson SD; Zheng L; Epstein AL; Stathopoulos A; Chen L; Schönthal AH; Chen TC
J Neurosurg; 2023 Sep; 139(3):822-830. PubMed ID: 36738464
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
